Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Wednesday, April 01, 2020
Horizon Discovery and Pharmahungary Group announced positive early-stage results for a novel micro-RNA therapeutic for ischemic heart diseases.
read more
Wednesday, August 05, 2020
Horizon Discovery announced TrueBinding has signed a set of commercial licenses for Horizon’s cGMP-compliant CHOSOURCE platform.
read more
Wednesday, March 17, 2021
HomTex has received EUA for its Level 1 Surgical masks, greenlighting their entry into the US government and medical PPE markets.
read more
In Sisseln, Switzerland, high-quality tablets, granules, effervescent tablets and hard capsules are produced by Aenova on a footprint of more than 6,000 m2 and a production area of more than 1,900 m2 by 160 employees - and with a completely CO2-free ...
read more
Hitachi Chemical Advanced Therapeutics Solutions (HCATS) announced they have signed a three-year clinical manufacturing agreement with GSK, a science-led global healthcare company
read more
Monday, September 23, 2019
Hikma Pharmaceuticals has launched a new prefilled syringe capability in the US through its affiliate, Hikma Pharmaceuticals USA Inc.
read more
Hi-Tech Pharmaceuticals has received third-party independent GMP certification of its Georgia and Pennsylvania facilities.
read more
Hetero has entered into a licensing agreement with Gilead Sciences for the manufacturing and distribution of Remdesivir for the treatment of Covid-19.
read more
HERMES PHARMA, previously a division of HERMES Arzneimittel GmbH, announced a separate legal entity named HERMES PHARMA GmbH. The forward-looking change will see both HERMES PHARMA GmbH and HERMES Arzneimittel GmbH operating independently but ...
read more
Shanghai Henlius Biotech announced the company's drug substance line and drug product line for trastuzumab biosimilar have passed the EU GMP on-site inspection.
read more
Heidelberg has signed a Master Service Agreement with ProBioGen for the antibodies used in two of their pipeline ATAC molecules.
read more
Heat Biologics, Inc. has unveiled enhanced allogeneic cell therapy manufacturing capabilities through its Scorpion Biological Services subsidiary.
read more
Heat Biologics, Inc. is changing the name of the company to NightHawk Biosciences, Inc., effective May 3, 2022, to better reflect the Company’s evolution, including expansion of its therapeutic pipeline, the vertical integration of capabilities from ...
read more
Tuesday, December 21, 2021
Heat Biologics, Inc. a clinical-stage biopharmaceutical company focused on developing first-in-class therapies to modulate the immune system, has executed a definitive merger agreement to acquire Elusys Therapeutics, a commercial-stage biodefense ...
read more
HCATS and apceth Biopharma have expanded their relationship with bluebird bio with long-term development and manufacturing services agreements for clinical and commercial supply for multiple therapies.
read more